Pandemic has made little positive impact on public’s view of pharma
A new report launched by Takeda has found that just 17% of UK adults surveyed felt their perception of pharma had improved based on the industry’s response to COVID-19
Read More
Tag: perception
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
